E
Edison Scientific
AI platform for autonomous scientific research discovery
About Edison Scientific
Edison Scientific positions itself as a next-generation research platform aimed at transforming how scientific investigation is conducted. The company’s website presents its offering as an “AI platform for scientific R&D” designed to empower researchers to move from hypothesis through to validated results within a single environment. On its site it states that the platform supports tasks including literature synthesis, data analysis, molecular design and producing publication-ready figures and reports—a workflow that traditionally spans many tools, datasets and manual interventions. Through automation and parallelisation, the company claims to accelerate the pace of discovery by enabling many research tasks to be performed simultaneously and at greater scale. The platform’s emphasis on synthesis of prior scientific literature and data suggests that it uses natural language processing and machine-learning techniques to help researchers absorb, organise and act on the growing body of scientific knowledge. By integrating these capabilities into a unified environment, Edison Scientific aims to streamline R&D workflows, reduce time to insight and enable organisations to more rapidly validate findings and publish outcomes. The target users are research organisations, R&D labs and scientific enterprises seeking to enhance productivity and uncover novel insights more quickly. While the company does not publicly disclose detailed financial or pricing models, the nature of its offering suggests a subscription or licence-based software model rather than hardware manufacturing or consumer retail. Overall, Edison Scientific presents a modern platform that leverages AI and data technologies to empower scientific discovery, merging literature, data and design into one workflow environment.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2025
- Headquarters
- San Francisco, United States
- Employees
- 73
- Open positions
- 19
- Dealroom signal
- 94.3/100
- Industry
- Health
- Sub-industry
- BioTechnology
- Sector
- Biotech & Life Sciences, Analytics, Data Analytics, Biotechnology, Drug Development, Core AI, Molecular, Big Data and Analytics
- Technology
- Artificial Intelligence, Big Data, Machine Learning
- Business model
- SaaS
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SEEDOther financing | Dec 2025 | $70M | $250M | Pillar VC · Dmitri Alperovitch · Spark Capital · Triatomic Capital | ↗ |
| SPINOUTOther financing | Jan 2025 | $0 | — | FutureHouse | ↗ |
Growth signals
Latest recorded traffic for Edison Scientific is 120K monthly website visits, down 36.8% over the last three months. Edison Scientific's team grew 170.4% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
| Company | Headquarters | Status | Employees | Total funding | Valuation |
|---|---|---|---|---|---|
Iris.aiAn AI based platform for R&D departments to make research documentation actionable |
Bærum, Norway | Operational | 42 | $15M | $8M |
GenialisCloud software for the visual exploration of next generation sequencing data |
Boston, United States | Operational | |||
AqemiaUsing quantum-physics with AI to speed up the discovery of novel drug molecules |
Paris, France | Operational | |||
OwkinCollaborative research platform and unique AI drug development solutions that make precision medicine a reality |
Paris, France | Operational | |||
LifebitEmpowers therapeutic leaders and pioneers in precision medicine on how to access and analyse siloed biomedical data |
London, United Kingdom | Operational | |||
UgenTecData analytics software for lab technicians |
Hasselt, Belgium | Acquired | |||
PharmaceleraQuantum mechanics and AI powered drug discovery platform |
Barcelona, Spain | Operational | |||
OmniscopeAI-powered immune databank for diagnostics and therapeutics |
Barcelona, Spain | Operational |
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed8 investors entered at this stage
Spark Capital
Triatomic Capital
Pillar VC
Dmitri Alperovitch
Susa Ventures
Jeff Dean
Olive Capital
Striker Venture Partners
Other known investors1 additional known investor
FutureHouse
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Edison Scientific on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Edison Scientific’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







